scholarly article | Q13442814 |
P356 | DOI | 10.1200/JCO.2012.41.7469 |
P698 | PubMed publication ID | 23109704 |
P50 | author | Georgia Chenevix-Trench | Q17517031 |
Geoffrey J. Lindeman | Q42337443 | ||
David Bowtell | Q47451431 | ||
P2093 | author name string | Gillian Mitchell | |
Paul A James | |||
Jonathan Beesley | |||
Alison H Trainer | |||
Joanne McKinley | |||
Marion Harris | |||
Xiao Qing Chen | |||
Sarah Sawyer | |||
P433 | issue | 35 | |
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | 4330-4336 | |
P577 | publication date | 2012-10-29 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | A role for common genomic variants in the assessment of familial breast cancer | |
P478 | volume | 30 |
Q62712290 | BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding |
Q37060585 | Behavioral and psychosocial responses to genomic testing for colorectal cancer risk |
Q40605693 | Breast cancer risk prediction using a clinical risk model and polygenic risk score |
Q37410693 | Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab |
Q89746441 | Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field |
Q38996690 | Clinical implications of genomics for cancer risk genetics |
Q37690575 | Common breast cancer risk variants in the post-COGS era: a comprehensive review |
Q52875169 | Diagnosis and Management of Hereditary Sarcoma. |
Q37699255 | Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling |
Q34767345 | Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer |
Q35832873 | Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility |
Q64080586 | Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer |
Q44770193 | Genetic risk transmission in a family affected by familial breast cancer |
Q47207156 | Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry |
Q37242239 | Genomic Biomarkers for Breast Cancer Risk |
Q64934338 | High-risk women's risk perception after receiving personalized polygenic breast cancer risk information. |
Q41441053 | Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features |
Q37583113 | Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status |
Q47822347 | Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks. |
Q32491318 | Monogenic and polygenic determinants of sarcoma risk: an international genetic study |
Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
Q47554600 | Population-Wide Genetic Risk Prediction of Complex Diseases: A Pilot Feasibility Study in Macau Population for Precision Public Healthcare Planning |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q35964605 | Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls |
Q33916899 | Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study |
Q36146953 | Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context |
Q41387543 | Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients |
Q92993050 | Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts |
Q54269445 | The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia. |
Q64240122 | Towards a more precise and individualized assessment of breast cancer risk |
Q37003285 | Tumour morphology predicts PALB2 germline mutation status |
Q33820594 | Two decades after BRCA: setting paradigms in personalized cancer care and prevention |
Q34586198 | Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles |
Search more.